BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6 related articles for article (PubMed ID: 38747019)

  • 1. Phenome-wide scanning identifies multiple diseases and disease severity phenotypes associated with HLA variants.
    Karnes JH; Bastarache L; Shaffer CM; Gaudieri S; Xu Y; Glazer AM; Mosley JD; Zhao S; Raychaudhuri S; Mallal S; Ye Z; Mayer JG; Brilliant MH; Hebbring SJ; Roden DM; Phillips EJ; Denny JC
    Sci Transl Med; 2017 May; 9(389):. PubMed ID: 28490672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying genetically driven clinical phenotypes using linear mixed models.
    Mosley JD; Witte JS; Larkin EK; Bastarache L; Shaffer CM; Karnes JH; Stein CM; Phillips E; Hebbring SJ; Brilliant MH; Mayer J; Ye Z; Roden DM; Denny JC
    Nat Commun; 2016 Apr; 7():11433. PubMed ID: 27109359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the role of HLA variants in neuroblastoma susceptibility through whole exome sequencing.
    Bonfiglio F; Lasorsa VA; Aievola V; Cantalupo S; Morini M; Ardito M; Conte M; Fragola M; Eva A; Corrias MV; Iolascon A; Capasso M
    HLA; 2024 May; 103(5):e15515. PubMed ID: 38747019
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 5.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 6.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.